This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Indasi Gopi Kumar: Innovator in Antiviral Compounds
Introduction
Indasi Gopi Kumar is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of antiviral research, particularly in the development of compounds that target the Hepatitis C virus.
Latest Patents
Indasi holds a patent for "Hepatitis C virus inhibitors." This patent is focused on antiviral compounds and specifically addresses combinations of compounds that can inhibit the function of the NS5A protein encoded by the Hepatitis C virus (HCV). The patent outlines compositions comprising such combinations and methods for inhibiting the function of the NS5A protein.
Career Highlights
Indasi Gopi Kumar is currently employed at Bristol-Myers Squibb Company, where he continues to work on innovative solutions in the field of antiviral therapies. His research has the potential to impact the treatment of Hepatitis C significantly.
Collaborations
Indasi has collaborated with notable colleagues, including Piyasena Hewawasam and John F Kadow, to advance his research and development efforts in antiviral compounds.
Conclusion
Indasi Gopi Kumar is a dedicated inventor whose work in antiviral research is paving the way for new treatments for Hepatitis C. His contributions are vital to the ongoing fight against viral infections.